Page last updated: 2024-08-16

propranolol and fluorodeoxyglucose f18

propranolol has been researched along with fluorodeoxyglucose f18 in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's5 (35.71)29.6817
2010's6 (42.86)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Egert, S; Nguyen, N; Schwaiger, M1
Cohade, C; Engles, JM; Ishimori, T; Nicely, O; Tatsumi, M; Wahl, RL1
Bruzelius, M; Jacobsson, H; Larsson, SA1
Jacobsson, H; Larsson, SA; Söderlund, V1
Gerbaudo, VH; Jager, V; Mollerach, AM; Parysow, O; Racioppi, S; San Roman, J1
Agrawal, A; Baghel, NS; Nair, N1
Angle, J; Finley, P; Isoda, T; Madar, I; Wahl, R1
Cheng, W; Dang, Y; Li, F; Wu, C; Xing, H; Zhu, Z1
Constantinescu, CC; Mirbolooki, MR; Mukherjee, J; Pan, ML1
Chen, X; Kang, F; Li, L; Ma, W; Ma, X; Shao, Y; Wang, J; Yang, W1
Conrad, G; Dressler, EV; George, A; Memon, AA; Sinha, P; Wagner, LM1
Aide, N; Bardet, S; Ciappuccini, R1
Brady, SL; Chism, CB; Doubrovin, M; Han, Y; Hossain, AKMM; Li, Y; Naik, MH; Rossi, M; Shulkin, BL; Wong, KK; Wu, S1
Bailly, M; Besse, H; Callaud, A; Metrard, G; Thibault, F1

Trials

1 trial(s) available for propranolol and fluorodeoxyglucose f18

ArticleYear
Pilot study of propranolol premedication to reduce FDG uptake in brown adipose tissue on PET scans of adolescent and young adult oncology patients.
    Pediatric hematology and oncology, 2017, Volume: 34, Issue:3

    Topics: Adipose Tissue, Brown; Adolescent; Adult; Blood Glucose; Blood Pressure; Female; Fluorodeoxyglucose F18; Heart Rate; Humans; Male; Neoplasms; Pilot Projects; Positron-Emission Tomography; Propranolol; Prospective Studies; Young Adult

2017

Other Studies

13 other study(ies) available for propranolol and fluorodeoxyglucose f18

ArticleYear
Contribution of alpha-adrenergic and beta-adrenergic stimulation to ischemia-induced glucose transporter (GLUT) 4 and GLUT1 translocation in the isolated perfused rat heart.
    Circulation research, 1999, Jun-25, Volume: 84, Issue:12

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Biological Transport; Cell Fractionation; Cell Membrane; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 4; Isoproterenol; Male; Monosaccharide Transport Proteins; Muscle Fibers, Skeletal; Muscle Proteins; Myocardial Ischemia; Myocardium; Organ Culture Techniques; Perfusion; Phentolamine; Phenylephrine; Propranolol; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Signal Transduction

1999
Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:7

    Topics: Acepromazine; Adipose Tissue, Brown; Adrenergic Agents; Anesthesia; Animals; Cold Temperature; Diazepam; Female; Fluorodeoxyglucose F18; Ketamine; Organ Specificity; Propranolol; Radiopharmaceuticals; Rats; Reserpine; Tissue Distribution; Tomography, Emission-Computed

2004
Reduction of FDG uptake in brown adipose tissue by propranolol.
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:9

    Topics: Adipose Tissue, Brown; Artifacts; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Propranolol; Radionuclide Imaging; Radiopharmaceuticals

2005
Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:7

    Topics: Adipose Tissue, Brown; Adult; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Propranolol; Radionuclide Imaging

2007
Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans.
    Clinical nuclear medicine, 2007, Volume: 32, Issue:5

    Topics: Adipose Tissue; Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Cohort Studies; Drug Interactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Propranolol

2007
A novel approach for reduction of brown fat uptake on FDG PET.
    The British journal of radiology, 2009, Volume: 82, Issue:980

    Topics: Adipose Tissue, Brown; Adolescent; Adrenergic beta-Antagonists; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasms; Positron-Emission Tomography; Propranolol; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging; Young Adult

2009
18F-fluorobenzyl triphenyl phosphonium: a noninvasive sensor of brown adipose tissue thermogenesis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:5

    Topics: Adipocytes, Brown; Animals; Biological Transport; Carbon Radioisotopes; Cold Temperature; Fluorodeoxyglucose F18; Male; Membrane Potential, Mitochondrial; Mitochondria; Norepinephrine; Organophosphorus Compounds; Propranolol; Rats; Technetium Tc 99m Sestamibi; Thermogenesis

2011
Brown adipose tissue can be activated or inhibited within an hour before 18F-FDG injection: a preliminary study with microPET.
    Journal of biomedicine & biotechnology, 2011, Volume: 2011

    Topics: Adipose Tissue, Brown; Animals; Female; Fluorodeoxyglucose F18; Hot Temperature; Injections; Mice; Positron-Emission Tomography; Propranolol; Time Factors

2011
Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.
    Synapse (New York, N.Y.), 2013, Volume: 67, Issue:2

    Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Blood Glucose; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Male; Norepinephrine Plasma Membrane Transport Proteins; Obesity; Propranolol; Propylamines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley

2013
Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:3

    Topics: Animals; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2

2014
Propranolol 18F-FDG PET/CT: A Noninvasive Approach for Differential Diagnosis of Hibernoma and Liposarcoma.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:11

    Topics: Administration, Oral; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lipoma; Liposarcoma; Positron Emission Tomography Computed Tomography; Propranolol

2017
Effect of Propranolol on 18F-Fluorodeoxyglucose Uptake in Brown Adipose Tissue in Children and Young Adults with Neoplastic Diseases.
    Molecular imaging and biology, 2021, Volume: 23, Issue:2

    Topics: Adipose Tissue, Brown; Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Child; Child, Preschool; Cold Temperature; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Propranolol; Radiopharmaceuticals; Tissue Distribution; Young Adult

2021
Extinction of Lipomatous Hypertrophy of the Interatrial Septum FDG Uptake With Propranolol Premedication.
    Clinical nuclear medicine, 2023, Jun-01, Volume: 48, Issue:6

    Topics: Atrial Septum; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Hypertrophy; Lipoma; Propranolol

2023